Localized lidocaine injection into the middle meningeal artery for chronic migraine relief
Official title: Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment: A Randomized, Double-Blinded, Parallel Phase 2 Clinical Trial
Run by Cooper Norcross Health · NCT07361549 · Data updated 2026-11-12
This phase 2 trial tests whether injecting lidocaine into brain arteries can reduce chronic migraine headaches in adults.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Cooper Norcross Health Academic / other |
| Locations | 1 site (Camden, New Jersey) |
| Status | Recruiting |
| Started | September 9, 2026 |
| Main results expected | December 2030 |
| Study ends | July 2031 |
| Registry record updated | October 1, 2026 |
| Trial ID | NCT07361549 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with chronic migraine who are referred for diagnostic cerebral angiography and able to provide informed consent.
✕Probably not a fit
Patients with certain safety exclusions or without response to the intervention may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with chronic migraine who have not found relief with standard treatments will receive lidocaine injections into two brain arteries during diagnostic angiography. The study compares lidocaine to saline to see if the approach can lessen headache frequency or severity. Researchers will monitor safety and collect data on headache impact and potential adverse effects. Participation requires informed consent and adherence to safety criteria, including assessments for intracranial pathology. The trial is led by Daniel A. Tonetti, MD, with SNIS Foundation and Stryker Neurovascular collaborators at Cooper University Health Care in Camden, NJ.
Why it matters
Potential benefit: If successful, patients may experience fewer or less severe migraines with a targeted, potentially durable relief strategy.
How similar studies have gone: Prior studies in similar approaches have shown mixed results; this represents a targeted, neurovascular delivery method that is relatively novel in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or above * Diagnosis of chronic migraine * Referred for diagnostic cerebral angiography to screen for intracranial pathology * Written informed consent able to be obtained from subject Exclusion Criteria: * Baseline HIT-6 score less than 50 * Pregnant, breastfeeding, or unwilling to practice contraception during participation in the study * Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data * Concomitant intracranial pathology (eg, intracranial malignancy) * Known hypersensitivity and/or contraindication to lidocaine or local anesthetics of the amide type * Taking chronic medications that, when co-administered with lidocaine and other local anesthetics, are at increased risk of developing methemoglobinemia (nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, acetaminophen, metoclopramide, quinine, sulfasalazine) * Known contraindications for angiography (eg, ESRD not requiring hemodialysis). Patients with contrast allergy with be premeditated with diphenhydramine and steroids. * Contraindication to anesthetic agents used for conscious sedation/monitored anesthesia care (MAC) * Concurrent participation in another research protocol for investigation of an experimental therapy * Per DSA imaging, presence of a cerebrovascular pathology known to cause headache (eg, arteriovenous malformation, dural arteriovenous fistula) * Per DSA imaging, presence of anastomosis or anatomical variation (eg, branches of middle meningeal artery) that could lead to increased procedural risk * Per DSA imaging, lack of endovascular access to either middle meningeal artery, or origin of the middle meningeal artery other than from the external carotid artery * Known or suspected inability to adhere to study protocol or protocol requirements, as per discretion of the Investigator or treating provider
Where it's running
-
Cooper University Health Care
Camden, New Jersey, United States Recruiting
Study contacts
- Study coordinator: Daniel A Tonetti, MD
- Email: tonetti-daniel@cooperhealth.edu
- Phone: (855) 306-3876
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
Immediate neck manual therapy effects on atlas position and neck muscles
This trial tests two upper neck manual therapy techniques to see their immediate effect on neck alignment, atlas position, and a neck muscle shape in adults with head and neck pain or headaches.
-
Vitamin IV lidocaine before fundal pressure to prevent headache after cesarean using spinal anesthesia
This trial tests whether a single intravenous dose of lidocaine given before fundal pressure during cesarean delivery reduces the chance or severity of headache.
-
Muscle Position and Dry Needling Efficacy
This study tests whether the position of the upper trapezius during dry needling changes pain and function for people with chronic neck pain.
-
Gentle ear vagus nerve stimulation to reduce headache after aneurysm stent coiling
This study will try a noninvasive ear vagus nerve stimulation device to see if it reduces postoperative headaches in adults having stent-assisted coiling or flow-diverter treatment for unruptured brain aneurysms.
-
Surgical masks versus N95 masks for operating room nurses' symptoms from surgical smoke
This test compares whether surgical masks or N95 masks reduce physical symptoms from surgical smoke in operating room nurses.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.